Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Fludarabine Phosphate in High grade B-cell lymphoma: NCT06323525 Clinical Landscape Report 2026
16 October 2026
NCT06323525 clinical landscape for High grade B-cell lymphoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Anlotinib Dihydrochloride in Melanoma: NCT06327698 Clinical Landscape Report 2026
16 October 2026
NCT06327698 clinical landscape for Melanoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Atezolizumab in Solid tumor: NCT06331598 Clinical Landscape Report 2026
16 October 2026
NCT06331598 clinical landscape for Solid tumor: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ifinatamab deruxtecan in Endometrial Carcinoma: NCT06330064 Clinical Landscape Report 2026
16 October 2026
NCT06330064 clinical landscape for Endometrial Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Dostarlimab-gxly in Microsatellite instability-high colorectal cancer: NCT06333314 Clinical Landscape Report 2026
16 October 2026
NCT06333314 clinical landscape for Microsatellite instability-high colorectal cancer: endpoints, sponsor, phase, geography, readouts, asset context and devel…
9 min read
Obecabatagene autoleucel in Systemic Lupus Erythematosus: NCT06333483 Clinical Landscape Report 2026
16 October 2026
NCT06333483 clinical landscape for Systemic Lupus Erythematosus: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
LB-LR-1109 in Solid tumor: NCT06332755 Clinical Landscape Report 2026
16 October 2026
NCT06332755 clinical landscape for Solid tumor: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tislelizumab in Lung Cancer: NCT06332274 Clinical Landscape Report 2026
16 October 2026
NCT06332274 clinical landscape for Lung Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
PIT-565 in Systemic Lupus Erythematosus: NCT06335979 Clinical Landscape Report 2026
16 October 2026
NCT06335979 clinical landscape for Systemic Lupus Erythematosus: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
MNPR-101-Zr in Lung Cancer: NCT06337084 Clinical Landscape Report 2026
16 October 2026
NCT06337084 clinical landscape for Lung Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Autologous CD22 CAR-T(Stanford University) in Lymphoplasmacytic Lymphoma: NCT06340737 Clinical Landscape Report 2026
16 October 2026
NCT06340737 clinical landscape for Lymphoplasmacytic Lymphoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
LMY-920 in Systemic Lupus Erythematosus: NCT06340750 Clinical Landscape Report 2026
16 October 2026
NCT06340750 clinical landscape for Systemic Lupus Erythematosus: endpoints, sponsor, phase, geography, readouts, asset context and development white space.